President · CME GROUP INC. (CME)

Bryan Durkin

A named executive officer of CME in every fiscal year CompBrief holds from FY2016 to FY2019. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$5,696,240

Salary $900,000Stock awards $2,977,009

FY2018: $6,588,383

2nd of 5 named executive officers at CME by FY2019 total.

5 named officers on file for CME, FY2019

Bryan Durkin’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 4 equity grants, each cited to its filing
  • CME’s disclosed peer group of 15 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how CME’s whole pay program stands against its peers

  • CME’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CME→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 18, 2020 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Bryan Durkin’s full pay file as a PDF — free

More than this page: up to 10 years of Bryan’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Bryan Durkin compensation by year

CME Summary Compensation Table · all 4 fiscal years held
In US dollars, as CME reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019
Salary$700,000$800,000$900,000$900,000
Bonus$0$0$0$0
Stock awards$2,319,131$2,726,645$3,504,344$2,977,009
Option awards$0$0$0$0
Non-equity incentive$904,056$1,317,781$1,963,757$1,375,101
Pension and deferred compensation$96,904$97,322$0$186,480
All other$162,834$151,323$220,282$257,650
Total$4,182,925$5,093,071$6,588,383$5,696,240

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CME GROUP INC. DEF 14A filed March 18, 2020, accession 0001193125-20-076774, and prior-year filings. Open the filing on EDGAR.

How this page was built: the CME GROUP INC. filed document, accession 0001193125-20-076774. Every figure is read from that document and cited to the page and table it appears in. Filed March 18, 2020.

$4.2M
$5.1M
$6.6M
$5.7M
FY16
FY17
FY18
FY19
SalaryNon-equity incentiveStock awardsAll other

Equity holdings

unvested awards at FY2019 year-end
TypeUnvested unitsValue at year-endExercise price
PSU19,216$3,857,036—
RSU6,520$1,308,694—
RSU5,847$1,173,610—
PSU4,570$917,290—
RSU4,570$917,290—
PSU3,899$782,607—
PSU3,261$654,548—
RSU2,402$482,129—

Per the Outstanding Equity Awards at Fiscal Year-End table in CME GROUP INC.'s FY2019 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

13 Form 4 lines since the FY2019 proxy (filed March 18, 2020)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-06-25Grant or award—645$225.0043,652
2026-02-23Sale—4,200$309.6543,007
2025-06-25Grant or award—532$273.0347,207
2024-09-03Gift—465$0.0055,142
2024-08-30Sale—7,593$214.5955,607
2024-06-25Grant or award—748$194.1063,200
2023-12-11Sale—5,560$216.3762,452
2023-06-26Grant or award—811$178.8968,012

The 8 most recent of 13 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

CME’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
Terrence DuffyChairman and Chief Executive Officer$11,867,214
Bryan Durkin · this pagePresident$5,696,240
John PietrowiczChief Financial Officer$3,300,001
Julie HolzrichterChief Operating Officer$2,999,330
Kevin KometerChief Information Officer$2,817,636

Board service

CME board · FY2021–FY2025
Director compensation in US dollars, as CME reports it. Most recent year first; a dash means the company reported no figure in that column.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$124,000$145,252—$0$269,252
FY2024$121,500$145,187—$0$266,687
FY2023$114,000$145,080—$0$259,080
FY2022$107,000$155,566—$0$262,566
FY2021$23,000$80,110—$94,087$198,856

Each year as the company reported it in CME's director compensation table. Totals are the company's own disclosed totals.

How this board is paid

Company policy: CME pays directors a $95,000 cash retainer and $145,000 in Stock (unrestricted shares). As stated in CME's FY2025 proxy.

The full CME compensation record

free company brief

This page is one person within CME's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the CME proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are CME's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Bryan Durkin's compensation dossier · One-time report. No refunds.